Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on September 21, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $117.76 ($1,118,720) on September 21, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 1,520 Common Stock at $492.97 ($749,321) on September 21, 2026; holds 332,423 after (Indirect).
- Open-market sale: disposed of 2,680 Common Stock at $493.60 ($1,322,851) on September 21, 2026; holds 329,743 after (Indirect).
- Open-market sale: disposed of 2,170 Common Stock at $494.82 ($1,073,751) on September 21, 2026; holds 327,573 after (Indirect).
- Open-market sale: disposed of 2,287 Common Stock at $495.71 ($1,133,694) on September 21, 2026; holds 325,286 after (Indirect).
- Open-market sale: disposed of 843 Common Stock at $496.62 ($418,654) on September 21, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on September 21, 2026; holds 394,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,698,271 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-21 | Option exercise/conversion | Common Stock | 9,500 | $118 | $1.1M | 333,943 |
| 2026-09-21 | Open-market sale | Common Stock | 1,520 | $493 | $749.3K | 332,423 |
| 2026-09-21 | Open-market sale | Common Stock | 2,680 | $494 | $1.3M | 329,743 |
| 2026-09-21 | Open-market sale | Common Stock | 2,170 | $495 | $1.1M | 327,573 |
| 2026-09-21 | Open-market sale | Common Stock | 2,287 | $496 | $1.1M | 325,286 |
| 2026-09-21 | Open-market sale | Common Stock | 843 | $497 | $418.7K | 324,443 |
| 2026-09-21 | Option exercise/conversion | Stock Option | 9,500 | — | — | 394,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-21 | Option exercise/conversion (9,500 shares) |
| 2026-09-21 | Open-market sale (1,520 shares) |
| 2026-09-21 | Open-market sale (2,680 shares) |
| 2026-09-21 | Open-market sale (2,170 shares) |
| 2026-09-21 | Open-market sale (2,287 shares) |
| 2026-09-21 | Open-market sale (843 shares) |
| 2026-09-21 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.